Cofoe Medical Technology Co.Ltd.

Cofoe Medical Technology Co.Ltd.

301087 · SHE · Healthcare / Medical Devices

47.03CNY-2.60 (-5.24%)

Price History

Full chart

Market Stats

Previous Close49.63
Open49.24
Day Range46.90 – 49.51
52-Week Range37.17 – 61.95
Volume2.31M
Market Cap12.29B
P/E (TTM)26.86
Forward P/E0.00
EPS1.94
Dividend Yield3.45%
Beta0.60
50-Day Avg51.67
200-Day Avg52.10

About

Cofoe Medical Technology Co.,Ltd. engages in the research and development, production, sales, and service of home care medical devices in China. The company offers medical and wellness products for various types of diseases treatment, damage therapy, daily health maintenance, and life quality improvement. It also offers rehabilitation aids products, such as hearing aids, electric wheelchair, and orthopedic/posture correction products; medical care products, such as dressing products and ostomy care products; health monitoring products for monitoring human physiological parameters including metabolic disease testing product and thermometers; respiratory support products including non-invasive ventilators and nebulizers; and TCM therapy and other products, such as physiotherapy devices. Additionally, the company offers logistics and warehousing services to third party medical product companies and on-line storemanagement services. Further, the company manufactures its products through the Original Design Model, through which, it collaborates with customers to develop designs of products itmanufactures; and the original equipment manufacturing model, through which its customers provide their designs and it manufactures. The company sells its products through both offline and online channels comprising direct sales primarily via self-owned and online stores, sales to third party pharmacy chain operators, sales to offline and online distributors, and through e-commerce platforms. It sells its products through its brands Cofoe, JOYOR HearingCare, Jerry Medical, Huazhou, and babaka. The company was formerly known as Hunan Cofoe Medical Technology Development Co., Ltd. and changed its name to Cofoe Medical Technology Co.,Ltd. in December 2026. Cofoe Medical Technology Co.,Ltd. was founded in 2005 and is headquartered in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Min Zhang
  • Employees5.08K
  • HeadquartersNo. 87, Changsha, China, 410000, China
  • Websitehttps://www.cofoe.com.cn

Leadership

  • Mr. Min ZhangChairman of the Board & President · b. 1979
  • Mr. Zhiming ZhangExecutive Vice Chairman · b. 1979
  • Mr. Wangpeng ChenVP & CFO · b. 1980
  • Mr. Bangjie HeExecutive Director · b. 1979
  • Mr. Xiaoqiao XueVP, Board Secretary & Executive Director · b. 1980
  • Mr. Hanqing ZuoVice President · b. 1990
  • Mr. Jie OuyangVice President · b. 1983
  • Mr. Xiangyu YuVice President · b. 1981
  • Pei ShenHead of Accounting Department
  • Ms. Ching Ching HaJoint Company Secretary · b. 1979

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.46B2.38B2.28B2.98B2.85B2.98B3.39B
Growth (%)-+62.46%-4.19%+30.82%-4.14%+4.53%+13.56%
Cost of Revenue901.47M1.35B1.28B1.80B1.62B1.44B1.59B
Gross Profit560.56M1.02B997.42M1.18B1.24B1.55B1.80B
Gross Margin38.34%43.04%43.83%39.51%43.28%51.86%53.16%
Operating Expense390.24M495.85M470.90M847.73M957.11M1.19B1.41B
Operating Income170.31M526.51M526.52M328.54M277.92M361.61M395.56M
Operating Margin11.65%22.17%23.14%11.04%9.74%12.12%11.68%
EBITDA184.70M521.78M580.41M444.91M435.42M551.68M625.88M
EBITDA Margin12.63%21.97%25.51%14.94%15.26%18.49%18.48%
Net Income123.69M423.95M428.86M301.68M254.28M311.75M371.61M
Net Income Margin8.46%17.85%18.85%10.13%8.91%10.45%10.97%
R&D16.01M44.26M70.59M118.42M114.33M96.41M87.28M
R&D as % of Total Revenue1.10%1.86%3.10%3.98%4.01%3.23%2.58%
Interest Expense30.61M1.44M6.81M10.85M13.50M17.91M16.07M
Interest Expense % of Total Revenue2.09%0.06%0.30%0.36%0.47%0.60%0.47%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.05B1.87B5.81B6.41B6.24B6.42B6.63B
Total Liabilities449.84M872.19M841.97M1.38B1.34B1.62B1.73B
Total Equity596.47M991.64M4.95B5.02B4.90B4.80B4.87B
Cash368.92M557.09M1.99B1.45B1.57B1.28B1.42B

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow57.40M495.77M239.99M98.91M393.82M663.39M695.73M
Capital Expenditure105.41M373.57M513.24M639.79M373.22M120.50M178.10M
Free Cash Flow-48.02M122.20M-273.25M-540.87M20.60M542.90M517.63M
Dividends Paid5.50M32.74M2.70M259.60M249.91M374.49M371.78M
FCF to OCF-83.65%24.65%-113.86%-546.83%5.23%81.84%74.40%
Dividend Paid to FCF-11.46%26.79%-0.99%-48.00%1213.28%68.98%71.82%

Earnings

Report DateDec 31, 2021Apr 19, 2022Aug 28, 2022Oct 26, 2022Dec 31, 2022Apr 25, 2023Aug 29, 2023Oct 29, 2023Dec 31, 2023Apr 28, 2024Jun 30, 2024Oct 29, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------
EPS Actual0.783.680.380.180.650.650.320.210.060.500.410.330.280.450.360.460.540.510.43
Surprise-------------------
Timing-Pre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap12.29B
Enterprise Value9.99B
Trailing P/E26.86
Forward P/E0.00
Price / Sales3.10
Price / Book2.35
EPS1.94
Book Value24.17
Revenue (TTM)3.96B
Gross Profit (TTM)2.16B
EBITDA507.86M
Profit Margin10.26%
Operating Margin8.66%
Return on Equity7.87%
Return on Assets3.53%
Shares Outstanding208.90M
Shares Float102.03M
Beta0.60
Dividend Yield3.45%
Dividend Rate1.80
Payout Ratio93.12%

Dividends

20261×
1.20Apr 10, 2026
20252×
0.60Sep 19, 20251.20May 30, 2025
20242×
0.60Oct 11, 20241.20Jun 12, 2024
20231×
1.20May 25, 2023
20221×
1.60May 20, 2022

Stock Splits

  • May 20, 20221.3:1